Visual function tests including the role of optical coherence tomography in neurofibromatosis 1
- 4 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Child's Nervous System
- Vol. 36 (10), 2363-2375
- https://doi.org/10.1007/s00381-020-04706-3
Abstract
Optic pathway glioma (OPG) is a common and significant complication of neurofibromatosis 1 (NF-1) that might lead to vision loss. The main reason to treat OPG is to preserve vision. Tumor location along the visual pathway largely dictates the presenting signs and symptoms. Clinical ophthalmic evaluation is focused on optic nerve functions including evaluation of pupils’ reaction to light, visual acuity, color vision, and visual field, as well as optic nerve appearance. An important relatively new ancillary test is optic coherence tomography (OCT) that measures the volume of retinal nerve fiber layer around the optic nerve and the ganglion cell layer-inner plexiform layer (GCL-IPL) of the macula, both proved to be strongly associated with losing vision in OPG. Accurate evaluation of vision functions plays a critical role in the decision of treatment. In this review, we describe the ophthalmological assessment including new biomarkers in clinical use. We also outline prognostic factors and current recommendations for surveillance and indications for treatment.Keywords
This publication has 74 references indexed in Scilit:
- Visual Outcomes in Pediatric Optic Pathway Glioma After Conformal Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysisNeuro-Oncology, 2012
- BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade AstrocytomaClinical Cancer Research, 2011
- Retinal Nerve Fiber Layer Thickness in Children With Optic Pathway GliomasAmerican Journal of Ophthalmology, 2011
- Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology programNeuro-Oncology, 2007
- Optic glioma warranting treatment in childrenEye, 2006
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1Current Opinion in Opthalmology, 2006
- Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal studyThe Journal of Pediatrics, 1994
- Optic gliomas in children with neurofibromatosis type 1The Journal of Pediatrics, 1989